SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Axonics, Inc. | 5,260,830 | 10.4% | EDGAR |
SC 13G/A | 2024-02-12 | FMR LLC | Axonics, Inc. | 1,179,132 | 2.3% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | Axonics, Inc. | 5,426,005 | 10.7% | EDGAR |
SC 13G/A | 2024-01-25 | BlackRock Inc. | Axonics, Inc. | 4,189,817 | 8.3% | EDGAR |
SC 13G/A | 2023-12-11 | FMR LLC | Axonics, Inc. | 5,517,426 | 10.9% | EDGAR |
SC 13G/A | 2023-03-10 | VANGUARD GROUP INC | Axonics, Inc. | 5,092,888 | 10.3% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Axonics, Inc. | 2,718,792 | 5.5% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Axonics, Inc. | 4,863,283 | 9.8% | EDGAR |
SC 13G/A | 2023-01-31 | BlackRock Inc. | Axonics, Inc. | 3,630,843 | 7.3% | EDGAR |
SC 13G/A | 2022-06-06 | Cooperatieve Gilde Healthcare IV U.A. | Axonics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | CREDIT SUISSE AG/ | Axonics, Inc. | 2,273,198 | 4.9% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | Axonics, Inc. | 3,919,384 | 8.5% | EDGAR |
SC 13G | 2022-02-09 | VANGUARD GROUP INC | Axonics, Inc. | 2,902,696 | 6.3% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Axonics, Inc. | 3,525,549 | 7.6% | EDGAR |
SC 13G/A | 2021-04-08 | Alfred E. Mann Foundation for Scientific Research | Axonics, Inc. | 1,602,970 | 4.0% | EDGAR |
SC 13G/A | 2021-02-12 | Flynn James E | Axonics Modulation Technologies, Inc. | 800,000 | 2.0% | EDGAR |
SC 13G | 2021-02-12 | CREDIT SUISSE AG/ | Axonics Modulation Technologies, Inc. | 2,530,981 | 6.4% | EDGAR |
SC 13G/A | 2021-02-08 | FMR LLC | Axonics Modulation Technologies, Inc. | 4,857,906 | 12.2% | EDGAR |
SC 13G/A | 2021-02-08 | Cooperatieve Gilde Healthcare IV U.A. | Axonics Modulation Technologies, Inc. | 1,376,733 | 3.5% | EDGAR |
SC 13G/A | 2021-02-05 | INTEGRATED CORE STRATEGIES (US) LLC | Axonics Modulation Technologies, Inc. | 31,427 | 0.0% | EDGAR |